Cambridge Investment Research Advisors’s Inovio Pharmaceuticals INO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,635
Closed -$10K 3359
2023
Q4
$10K Sell
1,635
-73
-4% -$446 ﹤0.01% 3167
2023
Q3
$8K Sell
1,708
-509
-23% -$2.38K ﹤0.01% 3119
2023
Q2
$12K Sell
2,217
-1,742
-44% -$9.43K ﹤0.01% 3143
2023
Q1
$39K Buy
3,959
+175
+5% +$1.72K ﹤0.01% 3064
2022
Q4
$71K Buy
3,784
+469
+14% +$8.8K ﹤0.01% 2948
2022
Q3
$69K Buy
3,315
+75
+2% +$1.56K ﹤0.01% 2911
2022
Q2
$67K Sell
3,240
-2,407
-43% -$49.8K ﹤0.01% 2915
2022
Q1
$243K Buy
5,647
+119
+2% +$5.12K ﹤0.01% 2723
2021
Q4
$331K Sell
5,528
-1,592
-22% -$95.3K ﹤0.01% 2437
2021
Q3
$612K Sell
7,120
-162
-2% -$13.9K ﹤0.01% 1890
2021
Q2
$810K Sell
7,282
-813
-10% -$90.4K ﹤0.01% 1698
2021
Q1
$901K Buy
8,095
+1,311
+19% +$146K ﹤0.01% 1499
2020
Q4
$720K Sell
6,784
-653
-9% -$69.3K ﹤0.01% 1526
2020
Q3
$1.04M Buy
7,437
+2,956
+66% +$411K 0.01% 1172
2020
Q2
$1.45M Buy
4,481
+3,594
+405% +$1.16M 0.01% 920
2020
Q1
$79K Buy
+887
New +$79K ﹤0.01% 2135
2019
Q4
Sell
-1,083
Closed -$27K 2442
2019
Q3
$27K Buy
1,083
+17
+2% +$424 ﹤0.01% 2314
2019
Q2
$38K Hold
1,066
﹤0.01% 2159
2019
Q1
$48K Buy
1,066
+83
+8% +$3.74K ﹤0.01% 2229
2018
Q4
$47K Hold
983
﹤0.01% 2091
2018
Q3
$66K Buy
983
+83
+9% +$5.57K ﹤0.01% 2174
2018
Q2
$42K Sell
900
-83
-8% -$3.87K ﹤0.01% 2164
2018
Q1
$56K Buy
983
+58
+6% +$3.3K ﹤0.01% 2096
2017
Q4
$46K Buy
925
+90
+11% +$4.48K ﹤0.01% 2068
2017
Q3
$63K Sell
835
-6
-0.7% -$453 ﹤0.01% 1944
2017
Q2
$79K Buy
+841
New +$79K ﹤0.01% 1861
2014
Q4
Sell
-2,022
Closed -$239K 1437
2014
Q3
$239K Buy
+2,022
New +$239K 0.01% 1210
2014
Q2
Sell
-1,819
Closed -$291K 1354
2014
Q1
$291K Sell
1,819
-61
-3% -$9.76K 0.01% 977
2013
Q4
$262K Buy
1,880
+353
+23% +$49.2K 0.01% 944
2013
Q3
$152K Buy
+1,527
New +$152K 0.01% 1090